AAAAAA

   
Results: 1-25 | 26-39
Results: 1-25/39
Identification of a gene frequently mutated in prostate tumors
Authors: Reding, DJ Zhang, KQ Salzman, SA Thomalla, JV Riepe, RE Suarez, BK Catalona, WJ Burmester, JK
Citation: Dj. Reding et al., Identification of a gene frequently mutated in prostate tumors, MED ONCOL, 18(3), 2001, pp. 179-187
Impaired prostate tumorigenesis in Egr1-deficient mice
Authors: Abdulkadir, SA Qu, ZC Garabedian, E Song, SK Peters, TJ Svaren, J Carbone, JM Naughton, CK Catalona, WJ Ackerman, JJH Gordon, JI Humphrey, PA Milbrandt, J
Citation: Sa. Abdulkadir et al., Impaired prostate tumorigenesis in Egr1-deficient mice, NAT MED, 7(1), 2001, pp. 101-107
Efficacy of first-generation Cavermap to verify location and function of cavernous nerves during radical prostatectomy: A multi-institutional evaluation by experienced surgeons
Authors: Walsh, PC Marschke, P Catalona, WJ Lepor, H Martin, S Myers, RP Steiner, MS
Citation: Pc. Walsh et al., Efficacy of first-generation Cavermap to verify location and function of cavernous nerves during radical prostatectomy: A multi-institutional evaluation by experienced surgeons, UROLOGY, 57(3), 2001, pp. 491-494
Autosomal dominant inheritance of prostate cancer: A confirmatory study
Authors: Verhage, BAJ Baffoe-Bonnie, AB Baglietto, L Smith, DS Bailey-Wilson, JE Beaty, TH Catalona, WJ Kiemeney, LA
Citation: Baj. Verhage et al., Autosomal dominant inheritance of prostate cancer: A confirmatory study, UROLOGY, 57(1), 2001, pp. 97-101
Frequent and early loss of the EGR1 corepressor NAB2 in human prostate carcinoma
Authors: Abdulkadir, SA Carbone, JM Naughton, CK Humphrey, PA Catalona, WJ Milbrandt, J
Citation: Sa. Abdulkadir et al., Frequent and early loss of the EGR1 corepressor NAB2 in human prostate carcinoma, HUMAN PATH, 32(9), 2001, pp. 935-939
Scatter factor-hepatocyte growth factor elevation in the serum of patientswith prostate cancer
Authors: Naughton, M Picus, J Zhu, XP Catalona, WJ Vollmer, RT Humphrey, PA
Citation: M. Naughton et al., Scatter factor-hepatocyte growth factor elevation in the serum of patientswith prostate cancer, J UROL, 165(4), 2001, pp. 1325-1328
Expression profiling reveals hepsin overexpression in prostate cancer
Authors: Magee, JA Araki, T Patil, S Ehrig, T True, L Humphrey, PA Catalona, WJ Watson, MA Milbrandt, J
Citation: Ja. Magee et al., Expression profiling reveals hepsin overexpression in prostate cancer, CANCER RES, 61(15), 2001, pp. 5692-5696
Polymorphisms in the prostate cancer susceptibility gene HPC2/ELAC2 in multiplex families and healthy controls
Authors: Suarez, BK Gerhard, DS Lin, J Haberer, B Nguyen, L Kesterson, NK Catalona, WJ
Citation: Bk. Suarez et al., Polymorphisms in the prostate cancer susceptibility gene HPC2/ELAC2 in multiplex families and healthy controls, CANCER RES, 61(13), 2001, pp. 4982-4984
Model-free linkage analysis with covariates confirms linkage of prostate cancer to chromosomes 1 and 4
Authors: Goddard, KAB Witte, JS Suarez, BK Catalona, WJ Olson, JM
Citation: Kab. Goddard et al., Model-free linkage analysis with covariates confirms linkage of prostate cancer to chromosomes 1 and 4, AM J HU GEN, 68(5), 2001, pp. 1197-1206
Replication linkage study for prostate cancer susceptibility genes
Authors: Suarez, BK Lin, J Witte, JS Conti, DV Resnick, MI Klein, EA Burmester, JK Vaske, DA Banerjee, TK Catalona, WJ
Citation: Bk. Suarez et al., Replication linkage study for prostate cancer susceptibility genes, PROSTATE, 45(2), 2000, pp. 106-114
Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging
Authors: Catalona, WJ Southwick, PC Slawin, KM Partin, AW Brawer, MK Flanigan, RC Patel, A Richie, JP Walsh, PC Scardino, PT Lange, PH Gasior, GH Loveland, KG Bray, KR
Citation: Wj. Catalona et al., Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging, UROLOGY, 56(2), 2000, pp. 255-260
Lowering PSA cutoffs to enhance detection of curable prostate cancer
Authors: Catalona, WJ Ramos, CG Carvalhal, GF Yan, Y
Citation: Wj. Catalona et al., Lowering PSA cutoffs to enhance detection of curable prostate cancer, UROLOGY, 55(6), 2000, pp. 791-795
Percentage of free PSA in black versus white men for detection and stagingof prostate cancer: A prospective multicenter clinical trial
Authors: Catalona, WJ Partin, AW Slawin, KM Naughton, CK Brawer, MK Flanigan, RC Richie, JP Patel, A Walsh, PC Scardino, PT Lange, PH deKernion, JB Southwick, PC Loveland, KG Parson, RE Gasior, GH
Citation: Wj. Catalona et al., Percentage of free PSA in black versus white men for detection and stagingof prostate cancer: A prospective multicenter clinical trial, UROLOGY, 55(3), 2000, pp. 372-376
Tissue factor expression and angiogenesis in human prostate carcinoma
Authors: Abdulkadir, SA Carvalhal, GF Kaleem, Z Kisiel, W Humphrey, PA Catalona, WJ Milbrandt, J
Citation: Sa. Abdulkadir et al., Tissue factor expression and angiogenesis in human prostate carcinoma, HUMAN PATH, 31(4), 2000, pp. 443-447
A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: Impact on cancer detection
Authors: Naughton, CK Miller, DC Mager, DE Ornstein, DK Catalona, WJ
Citation: Ck. Naughton et al., A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: Impact on cancer detection, J UROL, 164(2), 2000, pp. 388-392
Prostate cancer detection at low prostate specific antigen - Comment
Authors: Catalona, WJ
Citation: Wj. Catalona, Prostate cancer detection at low prostate specific antigen - Comment, J UROL, 163(3), 2000, pp. 811-812
Pain and morbidity of transrectal ultrasound guided prostate biopsy: A prospective randomized trial of 6 versus 12 cores
Authors: Naughton, CK Ornstein, DK Smith, DS Catalona, WJ
Citation: Ck. Naughton et al., Pain and morbidity of transrectal ultrasound guided prostate biopsy: A prospective randomized trial of 6 versus 12 cores, J UROL, 163(1), 2000, pp. 168-171
Identification and pine mapping of a region showing a high frequency of allelic imbalance on chromosome 16q23.2 that corresponds to a prostate cancersusceptibility locus
Authors: Paris, PL Witte, JS Kupelian, PA Levin, H Klein, EA Catalona, WJ Casey, G
Citation: Pl. Paris et al., Identification and pine mapping of a region showing a high frequency of allelic imbalance on chromosome 16q23.2 that corresponds to a prostate cancersusceptibility locus, CANCER RES, 60(13), 2000, pp. 3645-3649
Visual estimate of the percentage of carcinoma is an independent predictorof prostate carcinoma recurrence after radical prostatectomy
Authors: Carvalhal, GF Humphrey, PA Thorson, P Yan, Y Ramos, CG Catalona, WJ
Citation: Gf. Carvalhal et al., Visual estimate of the percentage of carcinoma is an independent predictorof prostate carcinoma recurrence after radical prostatectomy, CANCER, 89(6), 2000, pp. 1308-1314
Quality-of-life outcomes for men with prostate carcinoma detected by screening
Authors: Smith, DS Carvalhal, GF Schneider, K Krygiel, J Yan, Y Catalona, WJ
Citation: Ds. Smith et al., Quality-of-life outcomes for men with prostate carcinoma detected by screening, CANCER, 88(6), 2000, pp. 1454-1463
Primary treatment choices for men with clinically localized prostate carcinoma detected by screening
Authors: Yan, Y Carvalhal, GF Catalona, WJ Young, JD
Citation: Y. Yan et al., Primary treatment choices for men with clinically localized prostate carcinoma detected by screening, CANCER, 88(5), 2000, pp. 1122-1130
Genomewide scan for prostate cancer-aggressiveness loci
Authors: Witte, JS Goddard, KAB Conti, DV Elston, RC Lin, J Suarez, BK Broman, KW Burmester, JK Weber, JL Catalona, WJ
Citation: Js. Witte et al., Genomewide scan for prostate cancer-aggressiveness loci, AM J HU GEN, 67(1), 2000, pp. 92-99
A genome screen of multiplex sibships with prostate cancer
Authors: Suarez, BK Lin, J Burmester, JK Broman, KW Weber, JL Banerjee, TK Goddard, KAB Witte, JS Elston, RC Catalona, WJ
Citation: Bk. Suarez et al., A genome screen of multiplex sibships with prostate cancer, AM J HU GEN, 66(3), 2000, pp. 933-944
Use of human glandular kallikrein 2 for the detection of prostate cancer: Preliminary analysis
Authors: Partin, AW Catalona, WJ Finlay, JA Darte, C Tindall, DJ Young, CYF Klee, GG Chan, DW Rittenhouse, HG Wolfert, RL Woodrum, DL
Citation: Aw. Partin et al., Use of human glandular kallikrein 2 for the detection of prostate cancer: Preliminary analysis, UROLOGY, 54(5), 1999, pp. 839-845
Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when PSA levels are 2.51 to 4 ng/mL and digital rectal examination is not suspicious for prostate cancer: An alternative model
Authors: Catalona, WJ Partin, AW Finlay, JA Chan, DW Rittenhouse, HG Wolfert, RL Woodrum, DL
Citation: Wj. Catalona et al., Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when PSA levels are 2.51 to 4 ng/mL and digital rectal examination is not suspicious for prostate cancer: An alternative model, UROLOGY, 54(2), 1999, pp. 220-224
Risultati: 1-25 | 26-39